Advertisement
Screener

CURIS, INC. (CRIS) Operating Income

CURIS, INC. Operating Income

CURIS, INC. (CRIS) reported Operating Income of -$9.94 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-14

  • CURIS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$9.94M.
  • CURIS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$11.52M.
  • CURIS, INC. operating income (loss) for the quarter ending 2025-12-31 was $19.62M.
  • CURIS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$6.92M.
  • CURIS, INC. operating income (loss) for fiscal 2025 was -$5.71M.
  • CURIS, INC. operating income (loss) for fiscal 2024 was -$44.54M.
  • CURIS, INC. operating income (loss) for fiscal 2023 was -$48.33M.
  • CURIS, INC. operating income (loss) for fiscal 2022 was -$53.02M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 6 month as first filedOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 12 monthOperating Income (Loss) 12 month as first filed
2026-06-30-$9.94M
10-Q · filed 2026-08-14
-$21.46M
10-Q · filed 2026-08-14
-$1.84M
derived: sum of 3 quarters · filed 2026-08-14
-$8.76M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31-$11.52M
10-Q · filed 2026-05-13
$8.10M
derived: sum of 2 quarters · filed 2026-05-13
$1.18M
derived: sum of 3 quarters · filed 2026-05-13
-$7.08M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$19.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
$12.70M
derived: sum of 2 quarters · filed 2026-03-24
$4.44M
derived: sum of 3 quarters · filed 2026-08-14
-$5.71M
10-K · filed 2026-03-24
2025-09-30-$6.92M
10-Q · filed 2025-11-06
-$15.18M
derived: sum of 2 quarters · filed 2026-08-14
-$25.33M
10-Q · filed 2025-11-06
-$34.33M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$8.25M
10-Q · filed 2026-08-14
-$18.41M
10-Q · filed 2026-08-14
-$27.40M
derived: sum of 3 quarters · filed 2026-08-14
-$37.97M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31-$10.16M
10-Q · filed 2026-05-13
-$19.15M
derived: sum of 2 quarters · filed 2026-05-13
-$29.72M
derived: sum of 3 quarters · filed 2026-05-13
-$42.23M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$8.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
-$19.56M
derived: sum of 2 quarters · filed 2026-03-24
-$32.07M
derived: sum of 3 quarters · filed 2026-03-24
-$44.54M
10-K · filed 2026-03-24
2024-09-30-$10.57M
10-Q · filed 2025-11-06
-$23.08M
derived: sum of 2 quarters · filed 2025-11-06
-$35.55M
10-Q · filed 2025-11-06
-$47.75M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$12.51M
10-Q · filed 2025-08-05
-$24.98M
10-Q · filed 2025-08-05
-$37.18M
derived: sum of 3 quarters · filed 2025-08-05
-$49.55M
derived: sum of 4 quarters · filed 2025-08-05
2024-03-31-$12.47M
10-Q · filed 2025-05-06
-$24.67M
derived: sum of 2 quarters · filed 2025-05-06
-$37.04M
derived: sum of 3 quarters · filed 2025-05-06
-$49.17M
derived: sum of 4 quarters · filed 2025-05-06
2023-12-31-$12.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
-$24.57M
derived: sum of 2 quarters · filed 2025-03-31
-$36.70M
derived: sum of 3 quarters · filed 2025-03-31
-$48.33M
10-K · filed 2025-03-31
2023-09-30-$12.37M
10-Q · filed 2024-11-14
-$24.51M
derived: sum of 2 quarters · filed 2024-11-14
-$36.13M
10-Q · filed 2024-11-14
-$46.35M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$12.14M
10-Q · filed 2024-08-01
-$23.77M
10-Q · filed 2024-08-01
-$33.98M
derived: sum of 3 quarters · filed 2024-08-01
-$46.59M
derived: sum of 4 quarters · filed 2024-08-01
2023-03-31-$11.63M
10-Q · filed 2024-05-07
-$21.85M
derived: sum of 2 quarters · filed 2024-05-07
-$34.45M
derived: sum of 3 quarters · filed 2024-05-07
-$49.51M
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31-$10.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08
-$22.83M
derived: sum of 2 quarters · filed 2024-02-08
-$37.89M
derived: sum of 3 quarters · filed 2024-02-08
-$53.02M
10-K · filed 2024-02-08
2022-09-30-$12.61M
10-Q · filed 2023-11-02
-$27.67M
derived: sum of 2 quarters · filed 2023-11-02
-$42.80M
10-Q · filed 2023-11-02
-$55.37M
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30-$15.06M
10-Q · filed 2023-08-03
-$30.19M
10-Q · filed 2023-08-03
-$42.76M
derived: sum of 3 quarters · filed 2023-08-03
-$52.81M
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31-$15.13M
10-Q · filed 2023-05-04
-$27.70M
derived: sum of 2 quarters · filed 2023-05-04
-$37.75M
derived: sum of 3 quarters · filed 2023-05-04
-$48.40M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31-$12.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13
-$22.61M
derived: sum of 2 quarters · filed 2023-03-13
-$33.27M
derived: sum of 3 quarters · filed 2023-03-13
-$42.06M
10-K · filed 2023-03-13
2021-09-30-$10.05M
10-Q · filed 2022-11-09
-$20.70M
derived: sum of 2 quarters · filed 2022-11-09
-$29.50M
10-Q · filed 2022-11-09
-$35.77M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-$10.65M
10-Q · filed 2022-08-04
-$19.45M
10-Q · filed 2022-08-04
-$25.73M
derived: sum of 3 quarters · filed 2022-08-04
-$30.44M
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31-$8.80M
10-Q · filed 2022-05-05
-$15.07M
derived: sum of 2 quarters · filed 2022-05-05
-$19.79M
derived: sum of 3 quarters · filed 2022-05-05
-$25.22M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-$6.28M
10-K · filed 2021-03-16
-$10.99M
derived: sum of 2 quarters · filed 2021-11-09
-$16.42M
derived: sum of 3 quarters · filed 2021-11-09
-$24.90M
10-K · filed 2022-02-24
2020-09-30-$4.71M
10-Q · filed 2021-11-09
-$10.14M
derived: sum of 2 quarters · filed 2021-11-09
-$18.62M
10-Q · filed 2021-11-09
-$25.96M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$5.43M
10-Q · filed 2021-08-03
-$13.91M
10-Q · filed 2021-08-03
-$21.25M
derived: sum of 3 quarters · filed 2021-08-03
-$26.57M
derived: sum of 4 quarters · filed 2021-08-03
2020-03-31-$8.48M
10-Q · filed 2021-05-12
-$15.82M
derived: sum of 2 quarters · filed 2021-05-12
-$21.14M
derived: sum of 3 quarters · filed 2021-05-12
-$27.28M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31-$7.33M
10-K · filed 2021-03-16
-$12.66M
derived: sum of 2 quarters · filed 2021-03-16
-$18.80M
derived: sum of 3 quarters · filed 2021-03-16
-$24.36M
10-K · filed 2022-02-24
2019-09-30-$5.32M
10-K · filed 2021-03-16
-$11.46M
derived: sum of 2 quarters · filed 2021-03-16
-$17.02M
10-Q · filed 2020-11-10
-$22.17M
derived: sum of 4 quarters · filed 2021-03-16
2019-06-30-$6.14M
10-K · filed 2021-03-16
-$11.70M
10-Q · filed 2020-08-04
-$16.85M
derived: sum of 3 quarters · filed 2021-03-16
-$23.26M
derived: sum of 4 quarters · filed 2021-03-16
2019-03-31-$5.56M
10-K · filed 2021-03-16
-$10.71M
derived: sum of 2 quarters · filed 2021-03-16
-$17.12M
derived: sum of 3 quarters · filed 2021-03-16
-$24.98M
derived: sum of 4 quarters · filed 2021-03-16
2018-12-31-$5.15M
10-K · filed 2020-03-19
-$11.56M
derived: sum of 2 quarters · filed 2020-03-19
-$19.43M
derived: sum of 3 quarters · filed 2020-03-19
-$29.33M
10-K · filed 2020-03-19
2018-09-30-$6.42M
10-K · filed 2020-03-19
-$14.28M
derived: sum of 2 quarters · filed 2020-03-19
-$24.18M
10-Q · filed 2019-11-05
-$31.31M
derived: sum of 4 quarters · filed 2020-03-19
2018-06-30-$7.86M
10-K · filed 2020-03-19
-$17.77M
10-Q · filed 2019-08-09
-$24.89M
derived: sum of 3 quarters · filed 2020-03-19
-$39.37M
derived: sum of 4 quarters · filed 2020-03-19
2018-03-31-$9.91M
10-K · filed 2020-03-19
-$17.04M
derived: sum of 2 quarters · filed 2020-03-19
-$31.51M
derived: sum of 3 quarters · filed 2020-03-19
-$44.62M
derived: sum of 4 quarters · filed 2020-03-19
2017-12-31-$7.13M
10-K · filed 2019-03-26
-$21.60M
derived: sum of 2 quarters · filed 2019-03-26
-$34.71M
derived: sum of 3 quarters · filed 2019-03-26
-$49.76M
10-K · filed 2019-03-26
2017-09-30-$14.47M
10-K · filed 2019-03-26
-$27.58M
derived: sum of 2 quarters · filed 2019-03-26
-$42.63M
10-Q · filed 2018-11-01
-$53.40M
derived: sum of 4 quarters · filed 2019-03-26
2017-06-30-$13.11M
10-K · filed 2019-03-26
-$28.16M
10-Q · filed 2018-08-02
-$38.92M
derived: sum of 3 quarters · filed 2019-03-26
-$66.71M
derived: sum of 4 quarters · filed 2019-03-26
2017-03-31-$15.05M
10-K · filed 2019-03-26
-$25.82M
derived: sum of 2 quarters · filed 2019-03-26
-$53.60M
derived: sum of 3 quarters · filed 2019-03-26
-$64.28M
derived: sum of 4 quarters · filed 2019-03-26
2016-12-31-$10.76M
10-K · filed 2018-03-08
-$38.55M
derived: sum of 2 quarters · filed 2018-03-08
-$49.23M
derived: sum of 3 quarters · filed 2018-03-08
-$58.04M
10-K · filed 2018-03-08
2016-09-30-$27.79M
10-K · filed 2018-03-08
-$38.47M
derived: sum of 2 quarters · filed 2018-03-08
-$47.28M
10-Q · filed 2017-11-07
-$60.52M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30-$10.68M
10-K · filed 2018-03-08
-$19.49M
10-Q · filed 2017-08-03
-$32.73M
derived: sum of 3 quarters · filed 2018-03-08
-$37.58M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31-$8.81M
10-K · filed 2018-03-08
-$8.81M
10-Q · filed 2016-05-09
-$22.05M
derived: sum of 2 quarters · filed 2018-03-08
-$26.90M
derived: sum of 3 quarters · filed 2018-03-08
-$34.27M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31-$13.25M
10-K · filed 2017-03-09
-$13.25M
10-K · filed 2016-02-29
-$18.09M
derived: sum of 2 quarters · filed 2017-03-09
-$25.46M
derived: sum of 3 quarters · filed 2017-03-09
-$56.48M
10-K · filed 2018-03-08
-$56.48M
10-K · filed 2016-02-29
2015-09-30-$4.84M
10-K · filed 2017-03-09
-$4.84M
10-Q · filed 2015-11-09
-$12.21M
derived: sum of 2 quarters · filed 2017-03-09
-$43.23M
10-Q · filed 2016-11-03
-$43.23M
10-Q · filed 2015-11-09
-$48.05M
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30-$7.37M
10-K · filed 2017-03-09
-$7.37M
10-Q · filed 2015-08-06
-$38.39M
10-Q · filed 2016-08-04
-$38.39M
10-Q · filed 2015-08-06
-$43.20M
derived: sum of 3 quarters · filed 2017-03-09
-$47.96M
derived: sum of 4 quarters · filed 2017-03-09
2015-03-31-$31.02M
10-K · filed 2017-03-09
-$31.02M
10-Q · filed 2015-05-07
-$35.83M
derived: sum of 2 quarters · filed 2017-03-09
-$40.59M
derived: sum of 3 quarters · filed 2017-03-09
-$42.13M
derived: sum of 4 quarters · filed 2017-03-09
2014-12-31-$4.81M
10-K · filed 2016-02-29
-$9.56M
derived: sum of 2 quarters · filed 2016-02-29
-$11.11M
derived: sum of 3 quarters · filed 2016-02-29
-$15.86M
10-K · filed 2017-03-09
-$15.86M
10-K · filed 2015-02-24
2014-09-30-$4.75M
10-K · filed 2016-02-29
-$6.30M
derived: sum of 2 quarters · filed 2016-02-29
-$11.05M
10-Q · filed 2015-11-09
-$15.53M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$1.54M
10-K · filed 2016-02-29
-$6.30M
10-Q · filed 2015-08-06
-$10.78M
derived: sum of 3 quarters · filed 2016-02-29
-$10.65M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$4.75M
10-K · filed 2016-02-29
-$9.24M
derived: sum of 2 quarters · filed 2016-02-29
-$9.11M
derived: sum of 3 quarters · filed 2016-02-29
-$9.81M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$4.48M
10-K · filed 2015-02-24
-$4.35M
derived: sum of 2 quarters · filed 2015-02-24
-$5.06M
derived: sum of 3 quarters · filed 2015-02-24
-$9.42M
10-K · filed 2016-02-29
2013-09-30$130.37K
10-Q · filed 2014-11-10
-$575.83K
derived: sum of 2 quarters · filed 2015-02-24
-$4.93M
10-Q · filed 2014-11-10
-$18.37M
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30-$706.20K
10-K · filed 2015-02-24
-$5.06M
10-Q · filed 2014-08-07
-$18.50M
derived: sum of 3 quarters · filed 2015-02-24
-$23.46M
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31-$4.36M
10-K · filed 2015-02-24
-$17.79M
derived: sum of 2 quarters · filed 2015-02-24
-$22.75M
derived: sum of 3 quarters · filed 2015-02-24
-$25.18M
derived: sum of 4 quarters · filed 2015-02-24
2012-12-31-$13.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
-$18.39M
derived: sum of 2 quarters · filed 2015-02-24
-$20.82M
derived: sum of 3 quarters · filed 2015-02-24
-$18.62M
10-K · filed 2015-02-24
2012-09-30-$4.96M
10-Q · filed 2013-11-12
-$7.39M
derived: sum of 2 quarters · filed 2013-11-12
-$5.19M
10-Q · filed 2013-11-12
$2.38M
derived: sum of 4 quarters · filed 2014-03-13
2012-06-30-$2.43M
10-Q · filed 2013-08-08
-$226.41K
10-Q · filed 2013-08-08
$7.34M
derived: sum of 3 quarters · filed 2014-03-13
$2.52M
derived: sum of 4 quarters · filed 2014-03-13
2012-03-31$2.20M
10-Q · filed 2013-05-09
$9.76M
derived: sum of 2 quarters · filed 2014-03-13
$4.95M
derived: sum of 3 quarters · filed 2014-03-13
$329.50K
derived: sum of 4 quarters · filed 2014-03-13
2011-12-31$7.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
$2.75M
derived: sum of 2 quarters · filed 2014-03-13
-$1.87M
derived: sum of 3 quarters · filed 2014-03-13
-$7.20M
10-K · filed 2014-03-13
2011-09-30-$4.82M
10-Q · filed 2012-11-06
-$9.44M
derived: sum of 2 quarters · filed 2012-11-06
-$14.77M
10-Q · filed 2012-11-06
-$20.38M
derived: sum of 4 quarters · filed 2013-03-13
2011-06-30-$4.62M
10-Q · filed 2012-08-09
-$9.95M
10-Q · filed 2012-08-09
-$15.56M
derived: sum of 3 quarters · filed 2013-03-13
-$17.33M
derived: sum of 4 quarters · filed 2013-03-13
2011-03-31-$5.33M
10-Q · filed 2012-05-10
-$10.94M
derived: sum of 2 quarters · filed 2013-03-13
-$12.71M
derived: sum of 3 quarters · filed 2013-03-13
-$16.63M
derived: sum of 4 quarters · filed 2013-03-13
2010-12-31-$5.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13
-$7.38M
derived: sum of 2 quarters · filed 2013-03-13
-$11.30M
derived: sum of 3 quarters · filed 2013-03-13
-$5.64M
10-K · filed 2013-03-13
2010-09-30-$1.76M
10-Q · filed 2011-10-31
-$5.69M
derived: sum of 2 quarters · filed 2011-10-31
-$27.39K
10-Q · filed 2011-10-31
2010-06-30-$3.93M
10-Q · filed 2011-08-04
$1.74M
10-Q · filed 2011-08-04
2009-12-31-$10.04M
10-K · filed 2012-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Silexion Therapeutics Corp (SLXN)$0.001B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
VivoSim Labs, INC. (VIVS)United States$0.003B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70